Skip to main content
. 2021 Aug 31;10(17):3959. doi: 10.3390/jcm10173959

Table 1.

Demographic characteristics, chronic comorbidities, clinical events and procedures along hospital admission, and univariate analysis of variables associated with HA-AKI stage 3 in the study group.

Variables Total Stage 3 AKI Non-Stage 3 AKI Sig
n 165,893 995 (0.6) 164,898 (99.4)
Gender: Men. (n) % 74,962 (45.2) 517 (52.0) 74,445 (45.1) <0.001
Age (years). mean (SD) 54.9 (20.6) 67.1 (21) 53.9 (19.9) <0.001
Chronic comorbidities
Diabetes. (n) % 30,357 (18.3) 450 (45.2) 29,907 (18.1) <0.001
Hypertension. (n) % 65,554 (39.5) 707 (71.1) 64,847 (39.3) <0.001
Ischemic Heart Disease. (n) % 12,428 (7.5) 169 (17.1) 12,259 (7.4) <0.001
Ischemic Cerebrovascular disease. (n) % 11,446 (6.9) 78 (7.8) 11,368 (6.9) 0.136
Ischemic Peripheral vascular disease. (n) % 8706 (5.2) 93 (9.3) 8613 (5.2) <0.001
Chronic digestive disease. (n) % 9627 (5.8) 51 (5.1) 9576 (5.8) 0.198
Chronic liver disease. (n) % 5667 (3.4) 105 (10.6) 5562 (3.4) <0.001
Chronic congestive heart failure. (n) % 14,344 (8.6) 256 (25.7) 14,088 (8.5) <0.001
Chronic obstructive pulmonary disease. (n) % 23,272 (14.0) 424 (42.6) 22,848 (13.9) <0.001
Malignancy. (n) % 23,504 (14.2) 304 (30.6) 23,200 (14.1) <0.001
Rheumatologic disease. (n) % 6828 (4.1) 41 (4.1) 6787 (4.1) 0.529
Urologic disease. (n) % 11,926 (7.2) 148 (14.9) 11,778 (7.1) <0.001
Chronic Kidney disease stages <0.001
0 + I 137,385 (82.8) 583 (58.6) 136,802 (83)
II 16,252 (9.8) 109 (11.0) 16,143 (9.8)
III 9265 (5.6) 175 (17.6) 9090 (5.5)
IV 2991 (1.8) 128 (12.9) 2863 (1.7)
Clinical variables along hospital admission
Urgent admission. (n) % 108,577 (65.5) 947 (95.2) 107,630 (65.3) <0.001
Anaemia. (n) % 23,291 (14.0) 379 (38.1) 22,912 (13.9) <0.001
Acute respiratory failure. (n) % 7803 (4.7) 308 (31.0) 7495 (4.5) <0.001
Acute Hearth failure (n) % 6204 (3.7) 241 (24.2) 5963 (3.6) <0.001
SIRS. (n) % 2358 (1.4) 235 (23.6) 2123 (1.3) <0.001
Circulatory shock. (n) % 2018 (1.2) 280 (28.1) 1738 (1.1) <0.001
Major surgery. (n) % 61,583 (37.1) 408 (41.0) 61,675 (37.4) <0.001
Exposure to contrast media. (n) % 14,698 (8.9) 280 (28.1) 14,418 (8.7) <0.001
Exposure to nephrotoxic drugs. (n) % 85,863 (51.8) 677 (68.0) 85,186 (51.7) <0.001